Skip to main content
C

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,245 across all filing types
Latest filing 2022-04-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
2022年第一次临时股东大会决议公告
Regulatory Filings
2022-04-15 Chinese
关于对深圳证券交易所关注函回复的公告
Regulatory Filings
2022-04-12 Chinese
更正公告
Regulatory Filings
2022-04-12 Chinese
关于变更2022年第一次临时股东大会现场会议地点的公告
Regulatory Filings
2022-04-08 Chinese
关于出售量子高科(广东)生物有限公司100%股权的公告
Regulatory Filings
2022-03-31 Chinese
独立董事关于第五届董事会第十五次会议相关事项的独立意见
Regulatory Filings
2022-03-31 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.